paper-with-me

홈 › Papers

Toxicity Assessment in Preclinical Histopathology via Class-Aware Mahalanobis Distance for Known and Novel Anomalies

2026-02-02 · Olga Graf, Dhrupal Patel, Peter Groß, Charlotte Lempp, Matthias Hein, Fabian Heinemann arxiv

Drug-induced toxicity is a leading cause of preclinical and early-clinical failure, making early detection critical. Histopathology is the gold standard for toxicity assessment but relies on expert pathologists, creating a bottleneck for large-scale screening. We introduce an AI-based anomaly detection framework for whole-slide images (WSIs) of rodent liver that identifies healthy tissue and known pathologies (anomalies) and flags samples without training data as out-of-distribution (OOD). We evaluate OOD detection on two held-out categories: apoptosis (single-cell, near-OOD) and staining/processing artifacts (heterogeneous, far-OOD). We build a novel pixelwise-annotated dataset and fine-tune a pre-trained Vision Transformer (DINOv2) via Low-Rank Adaptation (LoRA) for segmentation, then use the Mahalanobis distance for OOD detection with class-specific thresholds. Optimizing the false positive rate subject to a predefined constraint on the false negative rate yields only 0.16% of pathological tissue classified as healthy and 0.35% of healthy tissue classified as pathological. Our false negative rate does not penalise cross-type errors, reflecting the safety-first objective of never overlooking a lesion; under the stricter correct-class criterion our method assigns 93.93% of ID and 89.38% of OOD findings to their own class. The study demonstrates technical feasibility of pixel-level anomaly detection for mouse liver histopathology, indicating possible applications in improving preclinical workflows and drug development efficiency.

📄 PDF Abstract BibTeX arXiv:2602.02124

Code (0)

등록된 구현이 없습니다.

Tasks

Anomaly Detection

Similar Papers 제목 키워드 기반

Multimodal AI predicts clinical outcomes of drug combinations from preclinical data

2025-03-04 · Yepeng Huang, Xiaorui Su, Varun Ullanat, Ivy Liang 외

Predicting clinical outcomes from preclinical data is essential for identifying safe and effective drug combinations. Current models rely on structural or target-based features to identify high-efficacy, low-toxicity dru…

Large Language Model

Effectiveness of Self-Assessment Software to Evaluate Preclinical Operative Procedures

2024-04-08 · Qi Dai, Ryan Davis, Houlin Hong, Ying Gu

Objectives: To assess the effectiveness of digital scanning techniques for self-assessment and of preparations and restorations in preclinical dental education when compared to traditional faculty grading. Methods: Forty…

Computational Image-based Stroke Assessment for Evaluation of Cerebroprotectants with Longitudinal and Multi-site Preclinical MRI

2022-03-11 · Ryan P. Cabeen, Joseph Mandeville, Fahmeed Hyder, Basavaraju G. Sanganahalli 외

While ischemic stroke is a leading cause of death worldwide, there has been little success translating putative cerebroprotectants from rodent preclinical trials to human patients. We investigated computational image-bas…

Whole-body Representation Learning For Competing Preclinical Disease Risk Assessment

2025-08-04 · Dmitrii Seletkov, Sophie Starck, Ayhan Can Erdur, Yundi Zhang 외 arxiv

Reliable preclinical disease risk assessment is essential to move public healthcare from reactive treatment to proactive identification and prevention. However, image-based risk prediction algorithms often consider one c…

Representation Learning

Prediction of Drug-Induced TdP Risks Using Machine Learning and Rabbit Ventricular Wedge Assay

2022-01-14 · Nan Miles Xi, Dalong Patrick Huang

The evaluation of drug-induced Torsades de pointes (TdP) risks is crucial in drug safety assessment. In this study, we discuss machine learning approaches in the prediction of drug-induced TdP risks using preclinical dat…

BIG-bench Machine LearningPrediction